Cargando…
The Analysis of Human Serum N-Glycosylation in Patients with Primary and Metastatic Brain Tumors
The identification of patients with different brain tumors is solely built on imaging diagnostics, indicating the need for novel methods to facilitate disease recognition. Glycosylation is a chemical modification of proteins, reportedly altered in several inflammatory and malignant diseases, providi...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825111/ https://www.ncbi.nlm.nih.gov/pubmed/33418875 http://dx.doi.org/10.3390/life11010029 |
_version_ | 1783640230296813568 |
---|---|
author | Váradi, Csaba Hajdu, Viktória Farkas, Flóra Gilányi, Ibolya Oláh, Csaba Viskolcz, Béla |
author_facet | Váradi, Csaba Hajdu, Viktória Farkas, Flóra Gilányi, Ibolya Oláh, Csaba Viskolcz, Béla |
author_sort | Váradi, Csaba |
collection | PubMed |
description | The identification of patients with different brain tumors is solely built on imaging diagnostics, indicating the need for novel methods to facilitate disease recognition. Glycosylation is a chemical modification of proteins, reportedly altered in several inflammatory and malignant diseases, providing a potential alternative route for disease detection. In this paper, we report the quantitative analysis of serum N-glycosylation of patients diagnosed with primary and metastatic brain tumors. PNGase-F-digested and procainamide-labeled serum glycans were purified by magnetic nanoparticles, followed by quantitative liquid chromatographic analysis. The glycan structures were identified by the combination of single quad mass spectrometric detection and exoglycosidase digestions. Linear discriminant analysis provided a clear separation of different disease groups and healthy controls based on their N-glycome pattern. Altered distribution of biantennary neutral, sialylated but nonfucosylated, and sialylated–fucosylated structures were found to be the most significant changes. Our results demonstrate that serum glycosylation monitoring could improve the detection of malignancy. |
format | Online Article Text |
id | pubmed-7825111 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-78251112021-01-24 The Analysis of Human Serum N-Glycosylation in Patients with Primary and Metastatic Brain Tumors Váradi, Csaba Hajdu, Viktória Farkas, Flóra Gilányi, Ibolya Oláh, Csaba Viskolcz, Béla Life (Basel) Communication The identification of patients with different brain tumors is solely built on imaging diagnostics, indicating the need for novel methods to facilitate disease recognition. Glycosylation is a chemical modification of proteins, reportedly altered in several inflammatory and malignant diseases, providing a potential alternative route for disease detection. In this paper, we report the quantitative analysis of serum N-glycosylation of patients diagnosed with primary and metastatic brain tumors. PNGase-F-digested and procainamide-labeled serum glycans were purified by magnetic nanoparticles, followed by quantitative liquid chromatographic analysis. The glycan structures were identified by the combination of single quad mass spectrometric detection and exoglycosidase digestions. Linear discriminant analysis provided a clear separation of different disease groups and healthy controls based on their N-glycome pattern. Altered distribution of biantennary neutral, sialylated but nonfucosylated, and sialylated–fucosylated structures were found to be the most significant changes. Our results demonstrate that serum glycosylation monitoring could improve the detection of malignancy. MDPI 2021-01-06 /pmc/articles/PMC7825111/ /pubmed/33418875 http://dx.doi.org/10.3390/life11010029 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Communication Váradi, Csaba Hajdu, Viktória Farkas, Flóra Gilányi, Ibolya Oláh, Csaba Viskolcz, Béla The Analysis of Human Serum N-Glycosylation in Patients with Primary and Metastatic Brain Tumors |
title | The Analysis of Human Serum N-Glycosylation in Patients with Primary and Metastatic Brain Tumors |
title_full | The Analysis of Human Serum N-Glycosylation in Patients with Primary and Metastatic Brain Tumors |
title_fullStr | The Analysis of Human Serum N-Glycosylation in Patients with Primary and Metastatic Brain Tumors |
title_full_unstemmed | The Analysis of Human Serum N-Glycosylation in Patients with Primary and Metastatic Brain Tumors |
title_short | The Analysis of Human Serum N-Glycosylation in Patients with Primary and Metastatic Brain Tumors |
title_sort | analysis of human serum n-glycosylation in patients with primary and metastatic brain tumors |
topic | Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825111/ https://www.ncbi.nlm.nih.gov/pubmed/33418875 http://dx.doi.org/10.3390/life11010029 |
work_keys_str_mv | AT varadicsaba theanalysisofhumanserumnglycosylationinpatientswithprimaryandmetastaticbraintumors AT hajduviktoria theanalysisofhumanserumnglycosylationinpatientswithprimaryandmetastaticbraintumors AT farkasflora theanalysisofhumanserumnglycosylationinpatientswithprimaryandmetastaticbraintumors AT gilanyiibolya theanalysisofhumanserumnglycosylationinpatientswithprimaryandmetastaticbraintumors AT olahcsaba theanalysisofhumanserumnglycosylationinpatientswithprimaryandmetastaticbraintumors AT viskolczbela theanalysisofhumanserumnglycosylationinpatientswithprimaryandmetastaticbraintumors AT varadicsaba analysisofhumanserumnglycosylationinpatientswithprimaryandmetastaticbraintumors AT hajduviktoria analysisofhumanserumnglycosylationinpatientswithprimaryandmetastaticbraintumors AT farkasflora analysisofhumanserumnglycosylationinpatientswithprimaryandmetastaticbraintumors AT gilanyiibolya analysisofhumanserumnglycosylationinpatientswithprimaryandmetastaticbraintumors AT olahcsaba analysisofhumanserumnglycosylationinpatientswithprimaryandmetastaticbraintumors AT viskolczbela analysisofhumanserumnglycosylationinpatientswithprimaryandmetastaticbraintumors |